IMR Press / FBE / Volume 9 / Issue 2 / DOI: 10.2741/E803

Frontiers in Bioscience-Elite (FBE) is published by IMR Press from Volume 13 Issue 2 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.


Fungal immunomodulatory proteins in the context of biomedicine

Show Less
1 Health Faculty, University of Manizales, Street 9a # 19-03, Manizales, Colombia
2 Department, Natural Sciences Faculty, University of Caldas, Street 65 # 26-10, Manizales, Colombia

*Author to whom correspondence should be addressed.


Front. Biosci. (Elite Ed) 2017, 9(2), 286–306;
Published: 1 June 2017

Fungi represent a large group of biodiverse microorganisms with potential applications ranging from industrial fields to the treatment for human diseases. A large number of pharmacologically active compounds including terpenoids, polysaccharides and proteins have been derived from these microorganisms. Fungal Immunomodulatory Proteins (FIPs) are a group of active compounds that are being considered for the treatment of asthma, allergy, autoimmune diseases and cancer. Here, we discuss the discovery, heterologous production bioactive mechanisms of action and their potential use in biomedicine.

Fungal Immunomodulatory Proteins
Recombinant Proteins
Fungal Bioactivity
Back to top